Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEVITT, L. P.
Right arrow Articles by PRAGER, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEVITT, L. P.
Right arrow Articles by PRAGER, D.
NEUROLOGY 1975;25:894
© 1975 American Academy of Neurology

Mononeuropathy due to vincristine toxicity

LAWRENCE P. LEVITT, M.D. and DAVID PRAGER, M.D.

Department of Medicine, Divisions of Neurology and Hematology/Medical Oncology, Allentown Hospital, Allentown, Pennsylvania.

Vincristine sulfate is a known neurotoxin. Peripheral neuropathy is the most common toxic manifestation and is usually of the symmetrical, mixed, sensory-motor type. With this report we alert other physicians to another feature of vincristine neurotoxicity, namely, mononeuropathy.

Received for publication December 30, 1974.

Reprint requests should be addressed to Dr. Levitt at Division of Neurology, Allentown Hospital, Allentown, PA 18104.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by AAN Enterprises, Inc.